NewsFeed
Headlines ASRM ESHRE FIGO ACOG Fertility and Sterility PCOS
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Stopping GLP-1 Drugs Before Pregnancy May Impact Maternal Health – Fertility Plus
Fertility Plus/LinkedIn
Apr 6, 2026, 16:13

Stopping GLP-1 Drugs Before Pregnancy May Impact Maternal Health – Fertility Plus

Fertility Plus shared a post on LinkedIn:

“The Hidden Rebound: The Impact of Stopping Weight-Loss Injections Before Pregnancy

Did you know that stopping weight-loss injections like GLP-1 drugs before pregnancy can lead to unexpected challenges? A major new study reveals that women who discontinued these medications gained over 3 kg more during pregnancy compared to those who never used them.

Key Findings:

  • Increased risk of going over recommended weight gain limits
  • Higher chances of preterm birth (from 13% to 17%)
  • Rising cases of gestational diabetes (15% to 20%)
  • Nearly half faced high blood pressure issues

While baby sizes and C-section rates remained similar, the impact on maternal health is significant. Experts suggest a quick ‘rebound’ effect in appetite and metabolism after stopping the drug, compounded by the stress of pregnancy.

If you’re considering pregnancy after using these medications, extra monitoring and support could make all the difference!

Scientific Reference:
Maya J et al. Gestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist Discontinuation. JAMA. 2025;334(24)

For inquiries”

Fertility Plus

Stay updated on all scientific advances in the field of fertility with Fertility News.

Fertility Fertility News Fertility Plus gestational diabetes GLP-1 drugs JAMA+ maternal health pregnancy preterm birth reproductive health Reproductive Medicine Weight-Loss Injections
NewsFeed